Literature DB >> 19176646

Unique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasia.

Volker Fendrich1, Jens Waldmann, Georg Feldmann, Katja Schlosser, Alexander König, Annette Ramaswamy, Detlef K Bartsch, Elias Karakas.   

Abstract

BACKGROUND: Epithelial and mesenchymal transitions (EMT) are essential for embryonic development and progression of non-invasive tumor cells into malignant, metastatic carcinomas. During embryogenesis, the parathyroid glands develop from pharyngeal pouches and migrate to their final destinations, densely enclosed by mesenchymal neural crest cells. In this study, we examined the expression of the EMT markers Snail, Twist and E-cadherin in normal parathyroid glands and benign and malignant parathyroid diseases.
METHODS: Using immunohistochemistry, we compared expression of E-cadherin, Snail and Twist in 25 patients with parathyroid adenoma, 25 patients with parathyroid hyperplasia, and nine patients with parathyroid cancer with normal parathyroid glands.
RESULTS: Normal parathyroid glands, parathyroid adenomas, and parathyroid hyperplasias showed a typical membranous E-cadherin staining pattern. Expression of Snail was found in 22/25 parathyroid adenomas and in all parathyroid hyperplasias. Twist was expressed in 22/25 of parathyroid adenomas and in 20/25 parathyroid hyperplasias. Snail and Twist positive cells were homogeneously distributed throughout the gland. However, in all nine parathyroid carcinomas, membranous E-cadherin staining was lost. In addition, the expression pattern of Snail and Twist was changed and mostly limited to the invasive front of cancer tissue samples.
CONCLUSION: Expression of Snail and Twist at the invasive front and consecutive loss of E-cadherin in parathyroid carcinomas suggests a key role of EMT in the tumorigenesis of this cancer. The unique expression pattern could help to distinguish between an adenoma and a non-metastatic carcinoma. Loss of E-cadherin and change of the expression pattern of Snail and Twist together should result in an en bloc resection or a close follow-up.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176646     DOI: 10.1530/EJE-08-0662

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  21 in total

1.  Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement.

Authors:  Rebecca A Whipple; Michael A Matrone; Edward H Cho; Eric M Balzer; Michele I Vitolo; Jennifer R Yoon; Olga B Ioffe; Kimberly C Tuttle; Jing Yang; Stuart S Martin
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Immunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma.

Authors:  Ralph Schneider; Stefanie Bartsch-Herzog; Annette Ramaswamy; Detlef K Bartsch; Elias Karakas
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

Review 3.  Pheochromocytomas and paragangliomas: assessment of malignant potential.

Authors:  Tim I M Korevaar; Ashley B Grossman
Journal:  Endocrine       Date:  2011-10-25       Impact factor: 3.633

4.  [Surgical treatment of parathyroid carcinoma : Does the initial en bloc resection improve the prognosis?]

Authors:  S Wächter; K Holzer; J Manoharan; C Brehm; I Mintziras; D K Bartsch; E Maurer
Journal:  Chirurg       Date:  2019-11       Impact factor: 0.955

5.  Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.

Authors:  Angelica M Silva-Figueroa; Roland Bassett; Ioannis Christakis; Pablo Moreno; Callisia N Clarke; Naifa L Busaidy; Elizabeth G Grubbs; Jeffrey E Lee; Nancy D Perrier; Michelle D Williams
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

6.  Conditioned media from human ovarian cancer endothelial progenitor cells induces ovarian cancer cell migration by activating epithelial-to-mesenchymal transition.

Authors:  L Teng; S Peng; H Guo; H Liang; Z Xu; Y Su; L Gao
Journal:  Cancer Gene Ther       Date:  2015-10-23       Impact factor: 5.987

7.  High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.

Authors:  Kojiro Ohba; Yasuyoshi Miyata; Tomohiro Matsuo; Akihiro Asai; Kensuke Mitsunari; Yohei Shida; Shigeru Kanda; Hideki Sakai
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

8.  HMGA2 is a driver of tumor metastasis.

Authors:  Asahiro Morishita; M Raza Zaidi; Akira Mitoro; Devipriya Sankarasharma; Matthias Szabolcs; Yasunori Okada; Jeanine D'Armiento; Kiran Chada
Journal:  Cancer Res       Date:  2013-05-30       Impact factor: 12.701

9.  Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas.

Authors:  Tony Navas; Robert J Kinders; Scott M Lawrence; Katherine V Ferry-Galow; Suzanne Borgel; Melinda G Hollingshead; Apurva K Srivastava; Sergio Y Alcoser; Hala R Makhlouf; Rodrigo Chuaqui; Deborah F Wilsker; Mariam M Konaté; Sarah B Miller; Andrea Regier Voth; Li Chen; Tomas Vilimas; Jyothi Subramanian; Lawrence Rubinstein; Shivaani Kummar; Alice P Chen; Donald P Bottaro; James H Doroshow; Ralph E Parchment
Journal:  Cancer Res       Date:  2019-11-15       Impact factor: 12.701

10.  Sorafenib inhibits tumor growth and improves survival in a transgenic mouse model of pancreatic islet cell tumors.

Authors:  Volker Fendrich; Katja Maschuw; Johannes Rehm; Malte Buchholz; Julia P Holler; Emily P Slater; Detlef K Bartsch; Jens Waldmann
Journal:  ScientificWorldJournal       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.